Ugo De Giorgi Selected Research

Ligands

2/2022	Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma.
1/2021	Spotlight on PSMA as a new theranostic biomarker for bladder cancer.
12/2017	Reduction of 68Ga-PSMA renal uptake with mannitol infusion: preliminary results.
10/2016	Androgen receptor signaling pathways as a target for breast cancer treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ugo De Giorgi Research Topics

Disease

120	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 10/2012
109	Neoplasms (Cancer) 03/2024 - 01/2002
84	Renal Cell Carcinoma (Grawitz Tumor) 05/2024 - 08/2013
48	Neoplasm Metastasis (Metastasis) 04/2024 - 09/2005
30	Carcinoma (Carcinomatosis) 04/2024 - 01/2017
26	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2002
25	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2023 - 01/2002
20	Disease Progression 01/2024 - 12/2018
16	Ovarian Neoplasms (Ovarian Cancer) 02/2024 - 05/2014
12	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 08/2016
11	Neutropenia 12/2023 - 06/2003
10	Fatigue 12/2023 - 08/2013
8	Human Influenza (Influenza) 11/2023 - 10/2018
7	Hypertension (High Blood Pressure) 02/2023 - 03/2014
7	Circulating Neoplastic Cells 12/2022 - 07/2009
7	Seminoma 10/2021 - 02/2005
6	Testicular Neoplasms (Testicular Cancer) 10/2023 - 02/2005
6	Kidney Neoplasms (Kidney Cancer) 07/2023 - 01/2016
6	Inflammation (Inflammations) 01/2021 - 01/2016
5	Diarrhea 02/2023 - 04/2014
5	Pain (Aches) 01/2022 - 03/2015
5	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2012 - 03/2005
4	Thrombocytopenia (Thrombopenia) 12/2023 - 08/2013
4	Pneumonia (Pneumonitis) 12/2023 - 07/2006
4	Stomatitis 02/2023 - 03/2015
3	Adenocarcinoma 12/2023 - 10/2018
3	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

44	enzalutamideIBA 01/2024 - 12/2014
35	PlatinumIBA 02/2024 - 12/2016
34	Immune Checkpoint InhibitorsIBA 04/2024 - 04/2018
28	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2016
27	Androgen Receptors (Androgen Receptor)IBA 02/2024 - 11/2015
27	abirateroneIBA 06/2023 - 06/2014
23	Sunitinib (Sutent)FDA Link 01/2024 - 08/2013
21	NivolumabIBA 01/2024 - 09/2016
18	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 01/2003
18	cabozantinibIBA 02/2023 - 01/2016
17	AndrogensIBA 02/2024 - 10/2012
17	pazopanib FDA Link 01/2024 - 08/2013
17	Docetaxel (Taxotere)FDA Link 01/2022 - 06/2014
16	Hormones (Hormone)IBA 03/2024 - 03/2012
15	Tyrosine Kinase InhibitorsIBA 05/2024 - 01/2015
15	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2015
14	Bevacizumab (Avastin)FDA Link 12/2023 - 06/2011
14	Prostate-Specific Antigen (Semenogelase)IBA 10/2023 - 06/2015
12	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 10/2004
10	pembrolizumabIBA 04/2024 - 01/2021
10	atezolizumabIBA 12/2023 - 01/2018
9	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 12/2016
9	Everolimus FDA Link 01/2022 - 10/2016
8	Carboplatin (JM8)FDA LinkGeneric 02/2024 - 04/2016
8	Cell-Free Nucleic AcidsIBA 12/2022 - 01/2015
7	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2023 - 06/2015
6	lenvatinibIBA 01/2024 - 04/2018
6	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2015
6	cabazitaxel FDA Link 09/2023 - 07/2015
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 03/2014
6	Abiraterone AcetateIBA 01/2023 - 05/2015
6	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 03/2014
5	Estrogen ReceptorsIBA 11/2023 - 08/2012
5	Proton Pump InhibitorsIBA 11/2023 - 01/2022
5	IpilimumabIBA 10/2023 - 01/2022
5	Chimeric Antigen ReceptorsIBA 03/2023 - 10/2019
5	AntigensIBA 01/2021 - 12/2017
5	CytokinesIBA 01/2019 - 01/2016
5	Imatinib Mesylate (Gleevec)FDA Link 10/2012 - 03/2005
4	Gemcitabine FDA Link 02/2024 - 10/2004
4	talazoparibIBA 01/2024 - 01/2021
4	Phenobarbital (Luminal)FDA Link 01/2024 - 01/2016
4	Leuprolide (Lupron)FDA LinkGeneric 01/2024 - 12/2021
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023 - 12/2016
4	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 10/2023 - 02/2016
4	Axitinib (AG 013736)IBA 01/2023 - 01/2016
4	taxaneIBA 01/2023 - 03/2015
4	Prednisone (Sone)FDA LinkGeneric 01/2023 - 01/2017
4	LigandsIBA 02/2022 - 10/2016
4	Hemoglobins (Hemoglobin)IBA 01/2022 - 04/2015
4	infigratinibIBA 01/2022 - 01/2018
4	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021 - 10/2018
4	human ERBB2 proteinIBA 03/2016 - 06/2011
3	liposomal doxorubicin (Doxil)FDA Link 02/2024 - 01/2019
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2024 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 11/2023 - 03/2012
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2023 - 01/2022
3	Trastuzumab (Herceptin)FDA Link 10/2023 - 06/2011
3	AnthracyclinesIBA 10/2023 - 03/2015

Therapy/Procedure

112	Therapeutics 03/2024 - 06/2003
89	Castration 03/2024 - 10/2012
76	Drug Therapy (Chemotherapy) 02/2024 - 01/2002
24	Immunotherapy 05/2024 - 08/2016
9	Radiotherapy 01/2021 - 02/2005
7	Nephrectomy 05/2024 - 01/2016
6	Salvage Therapy 11/2023 - 01/2002
6	Combination Drug Therapy (Combination Chemotherapy) 12/2021 - 01/2002
5	Precision Medicine 12/2023 - 12/2017
5	Cystectomy 01/2022 - 04/2018
4	Drug Tapering 01/2023 - 04/2014
4	Adjuvant Chemotherapy 01/2023 - 03/2015
4	Neoadjuvant Therapy 01/2023 - 01/2015
3	Duration of Therapy 03/2024 - 01/2020